PortfoliosLab logoPortfoliosLab logo
UTHR vs. AEVA
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

UTHR vs. AEVA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in United Therapeutics Corporation (UTHR) and Aeva Technologies, Inc. (AEVA). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, UTHR achieves a 11.79% return, which is significantly lower than AEVA's 73.87% return.


UTHR

1D
-0.94%
1M
-3.58%
YTD
11.79%
6M
13.59%
1Y
67.18%
3Y*
33.59%
5Y*
25.53%
10Y*
17.20%

AEVA

1D
0.35%
1M
70.15%
YTD
73.87%
6M
53.02%
1Y
10.48%
3Y*
49.22%
5Y*
-16.40%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

UTHR vs. AEVA - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
UTHR
United Therapeutics Corporation
11.79%38.09%60.46%-20.93%28.70%42.35%43.46%
AEVA
Aeva Technologies, Inc.
73.87%179.58%25.38%-44.29%-82.01%-48.01%51.46%

Correlation

The correlation between UTHR and AEVA is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.15

Correlation (3Y)
Calculated over the trailing 3-year period

0.16

Correlation (5Y)
Calculated over the trailing 5-year period

0.14

Correlation (All Time)
Calculated using the full available price history since Feb 27, 2020

0.13

Fundamentals

Market Cap

UTHR:

$25.71B

AEVA:

$1.45B

EPS

UTHR:

$27.00

AEVA:

-$2.52

PS Ratio

UTHR:

8.19

AEVA:

63.51

Total Revenue (TTM)

UTHR:

$3.17B

AEVA:

$20.97M

Gross Profit (TTM)

UTHR:

$2.74B

AEVA:

$971.00K

EBITDA (TTM)

UTHR:

$1.75B

AEVA:

$21.17M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

UTHR vs. AEVA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

UTHR
UTHR Risk / Return Rank: 8686
Overall Rank
UTHR Sharpe Ratio Rank: 8080
Sharpe Ratio Rank
UTHR Sortino Ratio Rank: 8787
Sortino Ratio Rank
UTHR Omega Ratio Rank: 8787
Omega Ratio Rank
UTHR Calmar Ratio Rank: 8989
Calmar Ratio Rank
UTHR Martin Ratio Rank: 8989
Martin Ratio Rank

AEVA
AEVA Risk / Return Rank: 4949
Overall Rank
AEVA Sharpe Ratio Rank: 4646
Sharpe Ratio Rank
AEVA Sortino Ratio Rank: 5555
Sortino Ratio Rank
AEVA Omega Ratio Rank: 5353
Omega Ratio Rank
AEVA Calmar Ratio Rank: 4646
Calmar Ratio Rank
AEVA Martin Ratio Rank: 4444
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

UTHR vs. AEVA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for United Therapeutics Corporation (UTHR) and Aeva Technologies, Inc. (AEVA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


UTHRAEVADifference
Sharpe ratioReturn per unit of total volatility

+1.27

Sortino ratioReturn per unit of downside risk

+1.76

Omega ratioGain probability vs. loss probability

1.37

1.12

+0.26

Calmar ratioReturn relative to maximum drawdown

4.13

0.14

+3.99

Martin ratioReturn relative to average drawdown

10.54

0.19

+10.35

UTHR vs. AEVA - Sharpe Ratio Comparison

The current UTHR Sharpe Ratio is 1.36, which is higher than the AEVA Sharpe Ratio of 0.09. The chart below compares the historical Sharpe Ratios of UTHR and AEVA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


UTHRAEVADifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.36

0.09

+1.27

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.73

-0.17

+0.90

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.49

Sharpe Ratio (All Time)

Calculated using the full available price history

0.38

-0.12

+0.51

Drawdowns

UTHR vs. AEVA - Drawdown Comparison

The maximum UTHR drawdown since its inception was -93.18%, roughly equal to the maximum AEVA drawdown of -97.71%. Use the drawdown chart below to compare losses from any high point for UTHR and AEVA.


Loading charts...

Drawdown Indicators


UTHRAEVADifference

Max Drawdown

Largest peak-to-trough decline

-93.18%

-97.71%

+4.53%

Max Drawdown (1Y)

Largest decline over 1 year

-16.35%

-75.68%

+59.33%

Max Drawdown (3Y)

Largest decline over 3 years

-33.00%

-75.68%

+42.68%

Max Drawdown (5Y)

Largest decline over 5 years

-33.00%

-96.02%

+63.02%

Max Drawdown (10Y)

Largest decline over 10 years

-55.56%

Current Drawdown

Current decline from peak

-8.73%

-76.91%

+68.18%

Average Drawdown

Average peak-to-trough decline

-35.31%

-70.68%

+35.37%

Ulcer Index

Depth and duration of drawdowns from previous peaks

6.39%

55.91%

-49.52%

Volatility

UTHR vs. AEVA - Volatility Comparison

The current volatility for United Therapeutics Corporation (UTHR) is 5.15%, while Aeva Technologies, Inc. (AEVA) has a volatility of 39.11%. This indicates that UTHR experiences smaller price fluctuations and is considered to be less risky than AEVA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


UTHRAEVADifference

Volatility (1M)

Calculated over the trailing 1-month period

5.15%

39.11%

-33.96%

Volatility (6M)

Calculated over the trailing 6-month period

26.01%

78.74%

-52.73%

Volatility (1Y)

Calculated over the trailing 1-year period

49.84%

114.82%

-64.98%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

35.13%

97.00%

-61.87%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

35.07%

91.35%

-56.28%

Dividends

UTHR vs. AEVA - Dividend Comparison

Neither UTHR nor AEVA has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

UTHR vs. AEVA - Financials Comparison

This section allows you to compare key financial metrics between United Therapeutics Corporation and Aeva Technologies, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00200.00M400.00M600.00M800.00M20222023202420252026
781.50M
6.26M
(UTHR) Total Revenue
(AEVA) Total Revenue
Values in USD except per share items

Frequently Asked Questions


UTHR and AEVA have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

AEVA has higher volatility (39.11%) compared to UTHR (5.15%). In terms of maximum drawdown, UTHR dropped -93.18% vs AEVA's -97.71%.

UTHR currently has the higher Sharpe Ratio (1.36 vs 0.09), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for UTHR and AEVA

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer